In pancreatic cancer, TSLP is associated with a reduced survival of patients, in which TSLP is produced by tumour-derived IL-1β-activated cancer-associated fibroblasts (CAFs) [17] and favours Th2 cell polarisation via myeloid DC [18]. Here, TSLP is linked to pancreatic neoplasm.